Ancestral susceptibility to colorectal cancerHUHN, Stefanie; PARDINI, Barbara; NACCARATI, Alessio et al.Mutagenesis. 2012, Vol 27, Num 2, pp 197-204, issn 0267-8357, 8 p.Article

The role of ABC transporters in progression and clinical outcome of colorectal cancerHLAVATA, I; MOHEINIKOVA-DUCHONOVA, B; VODICKA, P et al.Mutagenesis. 2012, Vol 27, Num 2, pp 187-196, issn 0267-8357, 10 p.Article

Global expression study in colorectal cancer on proteins with alkaline isoelectric point by two-dimensional difference gel electrophoresisMUTO, Taika; TANIGUCHI, Hirokazu; NAKAMURA, Yukiko et al.Journal of proteomics (Print). 2011, Vol 74, Num 6, pp 858-873, issn 1874-3919, 16 p.Article

What can we do about low colorectal cancer screening rates?RABENECK, Linda.The American journal of gastroenterology. 2007, Vol 102, Num 8, pp 1736-1738, issn 0002-9270, 3 p.Article

Preparation and Characterizations of Polyclonal Antibodies Against STAR Protein QKI7bQIUYAN LIU; YU LUO; XIAOTONG LI et al.Applied biochemistry and biotechnology. 2013, Vol 169, Num 8, pp 2273-2280, issn 0273-2289, 8 p.Article

Seeking genetic susceptibility variants for colorectal cancer: the EPICOLON consortium experienceCASTELLVI-BEL, Sergi; RUIZ-PONTE, Clara; LLOR, Xavier et al.Mutagenesis. 2012, Vol 27, Num 2, pp 153-159, issn 0267-8357, 7 p.Article

The influence of selenium and selenoprotein gene variants on colorectal cancer riskMEPLAN, Catherine; HESKETH, John.Mutagenesis. 2012, Vol 27, Num 2, pp 177-186, issn 0267-8357, 10 p.Article

Investigation of the effects of DNA repair gene polymorphisms on the risk of colorectal cancerTOMLINSON, Ian P. M; HOULSTON, Richard S; MONTGOMERY, Grant W et al.Mutagenesis. 2012, Vol 27, Num 2, pp 219-223, issn 0267-8357, 5 p.Article

Loss of MSH3 protein expression is frequent in MLH1-deficient colorectal cancer and is associated with disease progressionPLASCHKE, Jens; KRÜGER, Stefan; JESKE, Birgit et al.Cancer research (Baltimore). 2004, Vol 64, Num 3, pp 864-870, issn 0008-5472, 7 p.Article

Differences in nucleotide excision repair capacity between newly diagnosed colorectal cancer patients and healthy controlsSLYSKOVA, Jana; NACCARATI, Alessio; PARDINI, Barbara et al.Mutagenesis. 2012, Vol 27, Num 2, pp 225-232, issn 0267-8357, 8 p.Article

Survivin and molecular pathogenesis of colorectal cancerKIM, Paul J; PLESCIA, Janet; CLEVERS, Hans et al.Lancet (British edition). 2003, Vol 362, Num 9379, pp 205-209, issn 0140-6736, 5 p.Article

Gene expression variations: potentialities of master regulator polymorphisms in colorectal cancer riskPARDINI, Barbara; NACCARATI, Alessio; VODICKA, Pavel et al.Mutagenesis. 2012, Vol 27, Num 2, pp 161-167, issn 0267-8357, 7 p.Article

Reintroduction of oxaliplatin is associated with improved survival in advanced colorectal cancerDE GRAMONT, Aimery; BUYSE, Marc; CAROLA, Elisabeth et al.Journal of clinical oncology. 2007, Vol 25, Num 22, pp 3224-3229, issn 0732-183X, 6 p.Article

Impact of complete response to chemotherapy on overall survival in advanced colorectal cancer : Results from intergroup N9741DY, Grace K; KROOK, James E; POCKAJ, Barbara A et al.Journal of clinical oncology. 2007, Vol 25, Num 23, pp 3469-3474, issn 0732-183X, 6 p.Article

Statins and the risk of colorectal cancer : A meta-analysis of 18 studies involving more than 1.5 million patientsBONOVAS, Stefanos; FILIOUSSI, Kalitsa; FLORDELLIS, Christodoulos S et al.Journal of clinical oncology. 2007, Vol 25, Num 23, pp 3462-3468, issn 0732-183X, 7 p.Article

Applications of nanoparticles to diagnostics and therapeutics in colorectal cancerFORTINA, Paolo; KRICKA, Larry J; GRAVES, David J et al.Trends in biotechnology (Regular ed.). 2007, Vol 25, Num 4, pp 145-152, issn 0167-7799, 8 p.Article

Characterization of Three Amino-Functionalized Surfaces and Evaluation of Antibody Immobilization for the Multiplex Detection of Tumor Markers Involved in Colorectal CancerZHUGEN YANG; CHEVOLOT, Yann; LAURENCEAU, Emmanuelle et al.Langmuir. 2013, Vol 29, Num 5, pp 1498-1509, issn 0743-7463, 12 p.Article

Deleted in colorectal carcinoma suppresses metastasis in p53-deficient mammary tumoursKRIMPENFORT, Paul; SONG, Ji-Ying; PROOST, Natalie et al.Nature (London). 2012, Vol 482, Num 7386, pp 538-541, issn 0028-0836, 4 p.Article

Identification of distinctive protein expression patterns in colorectal adenomaLAM, Francis F; JANKOVA, Lucy; LES BOKEY, E et al.Proteomics. Clinical applications (Print). 2010, Vol 4, Num 1, pp 60-70, issn 1862-8346, 11 p.Article

BRAF mutation is frequently present in sporadic colorectal cancer with methylated hMLH1, but not in hereditary nonpolyposis colorectal cancerGUOREN DENG; BELL, Ian; CRAWLEY, Suzanne et al.Clinical cancer research. 2004, Vol 10, Num 1, pp 191-195, issn 1078-0432, 5 p., 1Article

EphB2 as a therapeutic antibody drug target for the treatment of colorectal cancerWEIGUANG MAO; LUIS, Elizabeth; POLAKIS, Paul et al.Cancer research (Baltimore). 2004, Vol 64, Num 3, pp 781-788, issn 0008-5472, 8 p.Article

Screening preferences for colorectal cancer: A patient demographic studySHEIKH, Rafiq A; KAPRE, Sheela; CALOF, Olga M et al.Southern medical journal (Birmingham). 2004, Vol 97, Num 3, pp 224-230, issn 0038-4348, 7 p.Article

Influence of demographics on colorectal cancerMOSTAFA, Gamal; MATTHEWS, Brent D; NORTON, H. James et al.The American surgeon. 2004, Vol 70, Num 3, pp 259-264, issn 0003-1348, 6 p.Conference Paper

Identification of phosphorylated serine-15 and -82 residues of HSPB1 in 5-fluorouracil-resistant colorectal cancer cells by proteomicsSAKAI, Akiko; OTANI, Mieko; MIYAMOTO, Akiko et al.Journal of proteomics (Print). 2012, Vol 75, Num 3, pp 806-818, issn 1874-3919, 13 p.Article

Interplay between oncogenic K-Ras and wild-type H-Ras in Caco2 cell transformationIKONOMOU, Georgia; KOSTOUROU, Vassiliki; SHIRASAWA, Senji et al.Journal of proteomics (Print). 2012, Vol 75, Num 17, pp 5356-5369, issn 1874-3919, 14 p.Article